01 1Hetero Drugs
01 1IRON SUCROSE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-04-30
Pay. Date : 2024-02-13
DMF Number : 39488
Submission : 2024-03-28
Status : Active
Type : II
20
Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is IRON SUCROSE, with a corresponding US DMF Number 39488.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 30, 2024, and payment made on February 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
